[1]
Mubashir, S., Gul, I., Rasool, A., Gul, S., Gulzar, G.M. and Wani, M.A. 2017. Side effect profile of hepatitis C treatment with peginterferon alpha-2b and ribavarin. International Journal of Basic & Clinical Pharmacology. 6, 7 (Jun. 2017), 1577–1584. DOI:https://doi.org/10.18203/2319-2003.ijbcp20172581.